Skip to main content

Table 3 Multivariate survival analysis of biochemical recurrence (BCR)-free survival in 128 patients with PCa

From: Association of microRNA-126 expression with clinicopathological features and the risk of biochemical recurrence in prostate cancer patients undergoing radical prostatectomy

Variables

BCR-free survival

Exp (B)

95% CI

P

Pathological stage

4.11

1.02–8.08

0.001

Lymph node metastasis

3.13

0.81–4.20

0.03

Angiolymphatic invasion

4.62

1.13–9.09

0.001

miR-126 expression

3.68

0.99–6.83

0.01

  1. Note: ‘NS’ refers to the difference without statistic significance.